
Contact us
About company
A developing optimized, proprietary in IVT mRNA with broad and long-acting therapeutic potential surpassing protein-based therapeutics.
AT
Unknown
Not verified company

A developing optimized, proprietary in IVT mRNA with broad and long-acting therapeutic potential surpassing protein-based therapeutics.